Test Code Epic LAB2373 C1q Complement, Functional, Serum
Additional Codes
SQ code C1Qm
Mayo code C1QFX
Reporting Name
C1Q Complement, Functional, SSpecimen Type
Serum RedPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Diagnosis of C1 deficiency
Investigation of a patient with an absent total complement level
Ordering Guidance
The total complement (CH50) assay (COM / Complement, Total, Serum) should be used as a screen for suspected complement deficiencies before ordering individual complement component assays. A deficiency of an individual component of the complement cascade will result in an undetectable CH50.
Specimen Required
Patient Preparation: Fasting preferred
Supplies: Sarstedt 5 mL Aliquot Tube (T914)
Collection Container/Tube: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. Immediately after specimen collection, place the tube on wet ice.
2. Centrifuge and aliquot serum into plastic vial.
3. Immediately freeze specimen.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum Red | Frozen | 14 days |
Reference Values
34-63 U/mL
Day(s) Performed
Monday through Friday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
86161
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
C1QFX | C1Q Complement, Functional, S | 87722-5 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
C1QFX | C1Q Complement, Functional, S | 87722-5 |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | Reject |
Gross icterus | OK |
Method Name
Automated Liposome Lysis Assay
Method Description
C1q complement activity is measured by mixing patient serum with a C1q-deficient serum. The lytic activity of the serum mixture is tested against sensitized, labeled liposomes. If lysis occurs, the patient serum must be the source of the C1q. The target liposomes are a commercial reagent (WAKO total complement CH50), and the assay is performed on an Advia XPT.(Unpublished Mayo method)